Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
3% Normal Saline vs Steroid Nebulization in Bronchiolitis
NCT06139029Phase 1Completed
- Sponsor
- Mardan Medical Complex
- Start
- Nov 2022
- Primary completion
- Mar 2023
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
Phase 1, randomised trial of hypertonic saline in bronchiolitis (2 arms), sponsored by Mardan Medical Complex. Primary endpoint: Efficacy of treatment (Discharged from hospital in ≤ 72 hours). Started Nov 2022; status: completed.
02
Drugs
hypertonic saline
03
Conditions
bronchiolitis
Beyond the preview
Go deeper on NCT06139029.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06139029.